bioMérieux S.A. (BMXMF)

R&D Expenses

€1.17B

TTM · Period ending: · EUR

BMXMF logo

BMXMF R&D Expenses

Latest reported€1.17B EUR
BMXMF R&D Expenses · EUR (€130.70M → €1.17B)
High-resolution chart · PNG

BMXMF r&d expenses history

Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. R&D Expenses — Annual fiscal periods (EUR)
Period endingR&D Expenses (EUR)
507,209,958
491,500,000
540,300,000
446,600,000
389,000,000
398,800,000
374,300,000
326,900,000
304,400,000
271,900,000
238,900,000
205,800,000
185,800,000
168,700,000
152,100,000
149,200,000
143,000,000
132,700,000
131,800,000
129,600,000
130,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.